Delivery Order SPE2DB20D2104-SPE2DB22FS64F
Award Date 5/5/22
Potential Completion Date 5/6/22
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is a delivery order (SPE2DB22FF6Q9) valued at $9,706.25, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of CARAFATE 1 GM/10 ML SUSP 420ML, a medication used to treat certain stomach and esophagus problems. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- The U.S. Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FGU13 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $3,980.34 Firm Fixed Price contract is for the supply of Carafate 1 GM/10 ML Suspension 420 ML, with a completion date of April 22, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this...
- This federal contract award, valued at $3,425.01, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carafate 1 GM/10 ML suspension, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop...
- The federal contract award is for the delivery of Carafate 1 GM/10 ML Suspension 420ML to the Defense Logistics Agency (DLA). The contract, valued at $2,938.02, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,789.63, is for the delivery of Carafate 1 GM/10 ML suspension in 420 ML quantities. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of May 14, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp, the prime...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Carafate 1 GM/10 ML Suspension in 420 ML bottles. The contract has a ceiling value of $3,983.93 and a completion date of July 19, 2023. The contract is a firm fixed-price type without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- This federal contract award, with an ID of SPE2DX15D2101|SPE2DX24F51RM, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $58,418.39 firm fixed-price delivery order is for the supply of Carafate 1 gm/10 ml suspension, a gastrointestinal medication, to support military healthcare programs. The contract has an ultimate completion date of May 2, 2024 and was awarded on...
- This contract award, valued at $1,895.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Carafate 1 GM/10 ML Suspension, a pharmaceutical product used for the treatment of gastrointestinal conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 31, 2023. The contract does not have a...
- This federal contract award SPE2DB22D2206|SPE2DB24FEH34, valued at $1,895.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Carafate 1 GM/10 ML Suspension, a pharmaceutical product used for various medical purposes. The award has an ultimate completion date of November 28, 2023. This contract is a delivery order with a firm fixed price, and it is not designated as a set-aside. Amerisourcebergen Drug...
- This federal contract award with ID SPE2DX15D3108|SPE2DX24F25QL was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,329.26 firm fixed-price delivery order is for CARAFATE 1 GM/10 ML SUSP 420ML, a pharmaceutical product. The award is not associated with a set-aside program and represents an open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999...